Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and Neck
NCT03614936 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2018-08-03
Summary
Use by Oncologists of Validated Geriatric Assessment Tools: G8 Screening Test and Certain Tests for Thorough Geriatric Evaluation
Conditions
- Inoperable Squamous Cell Cancer of the Head and Neck
Interventions
- OTHER
-
Geriatric Screening Test G8
Geriatric screening test (Oncodage-G8). The oncologist realizes it and proposes the oncological treatment which seems to him then the most adapted (treatment which can be different from that proposed after the oncological evaluation only).
- OTHER
-
Geriatric fragility test GERICO
GERICO geriatric frailty test (if possible the same day as the G8 and in any case in the same week): Realized by the oncologist, it includes: * the socio-cultural evaluation scale, * the ADL autonomy questionnaire, * assessment of locomotor disorders, * nutritional assessment, * the MMSE Cognitive Function Evaluation Questionnaire, * the GDS-4 mood rating scale, * the comorbidity assessment test (Charlson Index)
Sponsors & Collaborators
-
Gustave Roussy, Cancer Campus, Grand Paris
lead OTHER
Principal Investigators
-
Joel GUIGAY, MD, PhD · Centre Antoine Lacassagne
Eligibility
- Min Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-11
- Primary Completion
- 2019-06-30
- Completion
- 2019-06-30
Countries
- France
Study Locations
More Related Trials
-
Value of Geriatric Screening to Predict Postoperative Morbidity for Head and Neck Cancer
NCT03053310 ·Status: ACTIVE_NOT_RECRUITING
-
[68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas
NCT06794372 ·Status: RECRUITING ·Phase: PHASE2
-
Head and Neck Cancer Study Project in the Geriatric Population
NCT06998069 ·Status: RECRUITING ·Phase: PHASE3
-
Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC
NCT01864772 ·Status: COMPLETED ·Phase: PHASE2
-
Laryngeal Preservation in Pyriform Sinus Carcinoma
NCT00770393 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study Comparing Geriatric Co-Management With Geriatric Guided Supportive Care in Older Patients Receiving Chemoradiation Therapy for Their Head and Neck Cancer
NCT05239000 ·Status: COMPLETED ·Phase: NA
-
Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy
NCT05992610 ·Status: RECRUITING ·Phase: NA
-
TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study
NCT02752932 ·Status: COMPLETED ·Phase: NA
-
Predicting Toxicity in Elderly Patients With Head and Neck Cancer
NCT06344208 ·Status: RECRUITING
-
Patients with Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention
NCT06821243 ·Status: RECRUITING
-
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
NCT00158678 ·Status: COMPLETED ·Phase: PHASE3
-
Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)
NCT05789316 ·Status: COMPLETED ·Phase: NA
-
Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer
NCT02107235 ·Status: COMPLETED ·Phase: PHASE1
-
Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
NCT07180901 ·Status: RECRUITING ·Phase: NA
-
Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread
NCT03569436 ·Status: COMPLETED
-
P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC
NCT03077243 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
NCT06100497 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT01086826 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers
NCT04747054 ·Status: RECRUITING ·Phase: PHASE3
-
Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer
NCT01884623 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Nivolumab in Patients With Head and Neck Cancer.
NCT04050761 ·Status: COMPLETED
-
Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.
NCT01233843 ·Status: COMPLETED ·Phase: PHASE3
-
Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy
NCT02990936 ·Status: NOT_YET_RECRUITING
-
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
NCT04333537 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer
NCT06775756 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3